From idea to product
Biomedicals have developed an antibiotic free way to diminish the effects of a urinary tract infection (UTI) based on E. Coli bacteria, i.e., the UTI-Q technology.
Antibiotic resistance is one of the most urgent threats to the public’s health. The bacteria developing antibiotic resistant can cause illnesses that were once easily treatable with antibiotics to become untreatable. Antibiotic resistant bacteria are often more difficult to exterminate and more expensive to treat. In some cases, the antibiotic resistant infections can lead to serious disability or even death.
UTI-Q technology has been developed in Sweden and have been demonstrated to be efficient in uncomplicated UTI based on E. Coli bacteria. The technology will be introduced in Europe under the brand name UTI-Q®after thorough evaluation and CE marking.
The UTI-Q technology is patented and the brand name UTI-Q®is registered. It was awarded in Venture Cup competition to be among the Top 20 ideas in Sweden 2016 and have received financial support from the Swedish government.